American Board of Internal Medicine home page

Initial Certification indicates that physicians have met rigorous standards through intensive study, accredited training and evaluation and that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care.

MOC is a professionally determined standard that attests that an internist is staying current in knowledge and practice throughout his/her career.

For more than 75 years, Certification by ABIM has stood for the highest standard in internal medicine and its 20 subspecialties.

Cardiovascular Board Cardiovascular Disease Exam Committee

George W. Dec Jr., MD, Chair

Dr. Dec joined the Massachusetts General Hospital (MGH) Cardiology Division in 1984, and he served as Medical Director of the MGH Heart Failure and Cardiac Transplantation Program from its inception in 1984 until 2003. He also served as Associate Chief of Cardiology at MGH in 1996; Director of Clinical Cardiology from 1998 to 2003; and Chief of the Cardiology Division from 2001 to 2015. He directed the Partners HealthCare Heart Failure Disease Management Program for over a decade. Dr. Dec is the Roman DeSanctis Professor of Medicine at Harvard Medical School.

Dr. Dec is Chair of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee, and has been a member of the committee since 2007.

His research interests have focused on the diagnosis and treatment of dilated cardiomyopathy, myocarditis, advanced heart failure and cardiac transplantation management. He has been actively involved in the development of consensus guidelines on heart failure treatment as a member of the Heart Failure Society of America's Guidelines Committee. Dr. Dec has edited three textbooks in his fields of expertise: “Cardiac Allograft Rejection” (2001); “Heart Failure: A Comprehensive Guide to Diagnosis and Management” (2005); and “Heart Failure Clinics of America: Update on Myocarditis Diagnosis and Treatment” (2005).

He has served as site Principal Investigator for over 50 randomized clinical trials during the past 15 years and has published over 275 original articles, chapters, reviews and practice guideline documents. He is an Associate Editor for the Journal of the American College of Cardiology.

Dr. Dec graduated from Georgetown University with a bachelor's degree in chemistry. He received his medical degree from Johns Hopkins University School of Medicine and subsequently performed his medical residency and fellowship training in cardiovascular disease at Massachusetts General Hospital.

As of January 2017, Dr. Dec reported the following external relationships:

Service on data and safety monitoring boards for the following company, receiving honoraria:

  • Theranos Inc., to discuss a decentralized diagnostic platform to create access to health information.

Service on a research-related expert panel or advisory board for the following company, with compensation for travel expenses and honoraria:

  • Riverside Advisory Group, to discuss emerging technologies, receiving honoraria.

Work as an author or editor for following companies, with compensation as listed:

  • Journal of the American College of Cardiology, receiving compensation as Associate Editor.

Christopher P. Appleton, MD

Dr. Appleton, board certified in Internal Medicine and Cardiovascular Disease, is Professor of Medicine at the Mayo Clinic College of Medicine in Scottsdale, Arizona. He also holds Master's-Level Graduate Faculty Privileges in Clinical Research at the Mayo School of Graduate Medical Education, Scottsdale.

His clinical and research interests include left ventricular diastolic function and diastolic heart failure; pericardial diseases; physiology and treatment of hypertrophic cardiomyopathy, both obstructive and non-obstructive; restrictive cardiomyopathy; and left atrial function, in normal and disease states. Dr. Appleton began an active career in these topics in 1984, publishing both experimental and clinical research using cardiac ultrasound in new ways as a diagnostic tool. The majority of current research is now clinical. Dr. Appleton is considered a national/world expert on all four topics. He is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee.

Dr. Appleton received his medical degree from the University of Washington School of Medicine. He completed his internship, residency training and chief residency at the University of Arizona Health Sciences Center. He completed a fellowship in cardiac research at the Tucson Veterans Administration Hospital and a cardiovascular fellowship at Stanford University. He has been at the Mayo Clinic Arizona since 1993 and was Cardiovascular Division Chair from 1995 through 2004.

As of January 2017, Dr. Appleton reported no external relationships.

Dimitri C. Cassimatis, MD

Dr. Cassimatis is Director of the Coronary Care Unit at Emory University Hospital Midtown in Atlanta, Georgia, and divides his clinical time between Emory Midtown and Grady Memorial Hospital. He co-directs the first-year medical student cardiovascular pathophysiology module at Emory's School of Medicine, and is a small group faculty advisor there as well. Dr. Cassimatis is board certified in Internal Medicine, Cardiovascular Disease and Adult Transthoracic Echocardiography.

Before joining Emory as an Assistant Professor in 2010, Dr. Cassimatis spent 11 years as a physician in the United States Army. He served as Chief of the Cardiology Service at the U.S. Army's Landstuhl Regional Medical Center, and prior to this was Chief of the Cardiology Clinic there. He has served on both Ethics and Peer Review Committees on the clinical side, and Admissions and Curriculum Committees on the educational side.

Dr. Cassimatis is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. He sits on the Board of Directors of the Medical Association of Atlanta. He has received numerous awards, including two teaching awards from the Emory Cardiology fellows, two Meritorious Service Medals from the U.S. Army, and the Graves B. Erskine Award for top graduating fellow at Walter Reed in 2005.

Dr. Cassimatis received his bachelor's degree in biochemistry at the University of Chicago and his medical degree from Harvard University, where he was selected to give one of the commencement addresses at his graduation. He completed his internal medicine and cardiology training at Walter Reed Army Medical Center in Washington, DC.

As of July 2017, Dr. Cassimatis reported no external relationships.

Dr. Cassimatis serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Medical Association of Atlanta, member of Board of Trustees, receiving reimbursement for travel expenses.

Dr. Cassimatis also teaches a cardiology pathophysiology course for Emory University medical students, and also teaches cardiology fellows in clinical practice.

Mina K. Chung, MD

Dr. Chung is board certified in Internal Medicine, Cardiovascular Disease, and Clinical Cardiac Electrophysiology. She is a staff Clinical Cardiac Electrophysiologist in the Heart and Vascular Institute Department of Cardiovascular Medicine and in the Lerner Research Institute Department of Molecular Cardiology at the Cleveland Clinic. She is a Professor of Medicine in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

Dr. Chung is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. She is also active on committees within the American Heart Association (AHA), American College of Cardiology (ACC) and the Heart Rhythm Society (HRS). She has been Chair of the HRS Scientific and Clinical Documents Committee and is a member of the AHA Electrocardiology and Arrhythmias Committee of the Clinical Cardiology Council, the ACC EP Section Leadership Council, and the Cleveland Clinic Institutional Review Board. She has served on several consensus document and guideline writing committees and the National Institutes of Health (NIH) Clinical Trial Review Committee.

Dr. Chung has authored or co-authored numerous peer-reviewed publications. Her research interests include translational genomics of atrial fibrillation, clinical arrhythmia outcomes and electrophysiology device and ablation outcomes. She is a principal investigator for an NIH-funded grant on functional genomics of atrial fibrillation.

Dr. Chung received a bachelor's degree in chemistry from the University of California, San Diego, and her medical degree from Washington University School of Medicine in St. Louis, Missouri, where she also completed internal medicine residency and chief residency and cardiology and cardiac electrophysiology fellowships.

As of April 2017, Dr. Chung reported the following external relationships:

Funding for clinical trial expenses and staff, paid to the Cleveland Clinic, from the following company:

  • ZOLL, for a trial of a wearable cardioverter defibrillator post-heart attack.

Service on data and safety monitoring boards for the following company, with compensation for travel expenses:

  • Amarin, for a trial of an omega-3 fatty acid.

Work funded by educational grants from industry from the following companies:

  • Biotronik, for serving as a member of the steering committee for an international mentoring effort and education for women in cardiac electrophysiology, receiving reimbursement for travel expenses.
  • Medtronic, for Women in Electrophysiology, receiving reimbursement for travel expenses.

Work as an author or editor for following companies, with compensation as listed:

  • UpToDate, receiving compensation for authorship.
  • American Heart Association, receiving compensation as Associate Editor for Circulation: Arrhythmia and Electrophysiology.

Dr. Chung serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Cardiology, Member of the Electrophysiology Section Leadership Council, without compensation.
  • American Heart Association, Vice Chair, Arrhythmia and ECG Committee, without compensation.
  • Heart Rhythm Society, Chair of Scientific and Clinical Documents Committee, without compensation.

Larry S. Dean, MD

Dr. Dean is currently a Professor of Medicine and Surgery at the University of Washington (UW) School of Medicine and Director of the UW Medicine Regional Heart Center in Seattle, Washington. He is board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology. Dr. Dean specializes in interventional cardiology and is widely published in that field.

Previously, Dr. Dean was a Professor of Medicine at the University of Alabama (UAB) School of Medicine where he also served as an Assistant Medical Director of UAB Hospital. While there, he practiced general and interventional cardiology and was involved in the early development of intracoronary stents.

Dr. Dean is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Committee. He is a fellow of the American College of Cardiology, the American Heart Association and is a Master Interventionalist of the Society for Cardiovascular Angiography and Interventions (SCAI). He is also a past President of SCAI. In addition, he is a member of the American Association for Physician Leadership and the American Medical Informatics Association.

He received his undergraduate degree and his medical degree from the University of Alabama. Following medical school, Dr. Dean served his internship and residency at the University of Washington School of Medicine and received cardiology training, including interventional cardiology, at the University of Alabama School of Medicine. He also holds a certificate in Medical Management from the University of Washington.

As of January 2017, Dr. Dean reported the following external relationships:

Funding for clinical trial expenses and staff, paid to the University of Washington School of Medicine, from the following company:

  • Edwards LifeSciences, for trials evaluating the SAPIEN heart valve (PARTNER trials).

Attendance at investigators' meetings, with compensation as listed from the following company:

  • Edwards LifeSciences, held in conjunction with major professional meetings where study issues were discussed with investigators involved with trials evaluating the SAPIEN heart valve (PARTNER trials); receiving reimbursement for travel expenses.

Dr. Dean serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Cardiology, serves on the Transcatheter Valve Therapy Registry Stakeholders Committee, receiving reimbursement for per diem and travel expenses.
  • Society for Cardiovascular Angiography and Interventions, Member, Budget and Finance Committee, receiving no compensation.

William Lane Duvall, MD

Dr. Duvall is the Director of Nuclear Cardiology at Hartford Hospital in Hartford, Connecticut, and Associate Professor of Medicine at the University of Connecticut School of Medicine. He is board certified in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology and Adult Echocardiography.

Previously, Dr. Duvall worked as a non-invasive cardiologist at Mount Sinai Medical Center for almost 10 years, most recently serving as an Associate Professor of Medicine. During his time there, he worked full-time in the echocardiography and nuclear cardiology laboratories and served in several administrative positions including in the fellowship program and the cardiac care unit.

Dr. Duvall is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. He is actively involved with the American Society of Nuclear Cardiology, currently serving on the Board of Directors. Additionally, he is a member of the Registry Oversight Committee and the Deputy Chair of the Health Policy Committee.

Dr. Duvall received a bachelor’s degree in molecular biology from Princeton University and his medical degree from Yale University. He completed his internal medicine internship and residency at Duke University Medical Center, and his cardiovascular disease fellowship at Mount Sinai Medical Center in New York City.

As of July 2017, Dr. Duvall reported the following external relationships:

Dr. Duvall serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American Society of Nuclear Cardiology, Board of Directors, Health Care Policy Committee, ImageGuide Registry Committee, Nuclear Cardiology Today Speaker, receiving honoraria and reimbursement for travel expenses.

Mario J. Garcia, MD

Dr. Garcia is board certified in Internal Medicine, Cardiovascular Disease and Echocardiography. He is Chief of Cardiology at Montefiore Medical Center, and co-Director of the Montefiore Einstein Center for Heart and Vascular Care. He is also Professor of Medicine and Radiology, Albert Einstein College of Medicine.

Dr. Garcia's previous positions include Director of Cardiac Imaging and Professor of Medicine and Radiology at Mount Sinai Hospital and Medical School; Director of Cardiac Imaging, Cleveland Clinic; and Assistant Professor of Medicine at Dartmouth Hitchcock and the White River Junction VA Medical Center.

He is presently a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee, National Board of Echocardiography, Montefiore Accountable Care Organization, American Heart Association – Founder Affiliate, Centro de Diagnóstico y Medicina Avanzada, and Conferencias Médicas y Telemedicina (Santo Domingo, Dominican Republic). He is a past member of the Board of the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography and the Intersocietal Accreditation Council.

Dr. Garcia received his medical degree from the Universidad Nacional Pedro Henríquez Ureña, Dominican Republic. He completed training in internal medicine and cardiology at St. Vincent's Medical Center in Bridgeport, Connecticut; nuclear cardiology at Massachusetts General Hospital; and echocardiography at Cleveland Clinic.

As of January 2017, Dr. Garcia reported the following external relationships:

Work as an author or editor for the following companies, with compensation as listed:

  • Elsevier, receiving royalties for textbook authorship.
  • Wolters Kluwer Health, receiving royalties for textbook authorship.

Dr. Garcia serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • National Board of Medical Examiners, National Board of Echocardiography Exam Committee, receiving reimbursement for travel expenses.

Marie D. Gerhard-Herman, MD

Bio coming soon.

As of January 2017, Dr. Gerhard-Herman reported the following external relationships:

Dr. Gerhard-Herman serves in significant roles with the following organization(s), receiving reimbursement or compensation as listed:

  • American College of Cardiology, Chair, Peripheral Arterial Disease (PAD) Guideline Writing Committee; receiving reimbursement for travel expenses.
  • Progeria Research Foundation, grant funding provided to Brigham and Women's Hospital for vascular ultrasound imaging to assess phenotype and response to therapy in children with Hutchinson-Gilford (HG) progeria syndrome; receiving salary support.

Jonathan L. Halperin, MD

Dr. Halperin, a board certified internist and cardiologist, is the Robert and Harriet Heilbrunn Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai. He joined the Mount Sinai faculty in 1980 and played a key role in the formation of the Cardiovascular Institute, a leading center for integrated cardiovascular research, education and patient care. Today he is Associate Director of the Institute.

As the principal cardiologist responsible for the design and execution of the Stroke Prevention in Atrial Fibrillation (SPAF) clinical trials, he helped develop antithrombotic strategies to prevent stroke among the millions of people with atrial fibrillation. He was co-Chairman of the Executive Steering Committee of the SPORTIF trials, which evaluated the first oral direct thrombin inhibitor, and served on the Executive Steering Committee of the ROCKET-AF trial, which evaluated the first oral factor Xa inhibitor for this indication. He is currently engaged in studies developing therapeutic approaches to an array of cardiovascular disease states, including atrial fibrillation.

Dr. Halperin is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. He was the recipient of the Heart of New York Award for Achievement in Cardiovascular Science and Medicine and the Jacobi Medallion in recognition of distinguished achievement in the field of medicine at the Mount Sinai Medical Center, as well as several teaching awards. He serves on consensus and writing panels that issue clinical practice guidelines for management of patients with various cardiovascular disorders, is Chair of the ACC/AHA Task Force on Practice Guidelines, co-Chair of the ACC Clinical Competence Committee, and Deputy Editor of the Journal of the American College of Cardiology. He is also past President of the Society for Vascular Medicine and the New York City affiliate of the American Heart Association.

Dr. Halperin was educated at Columbia University and the Boston University School of Medicine.

As of January 2017, Dr. Halperin reported the following external relationships:

Attendance at investigators' meetings, with compensation for travel expenses and honoraria from the following company:

  • Pfizer, for the EMANATE trial, investigating the use of the oral factor Xa inhibitor, apixaban, in patients with atrial fibrillation undergoing cardioversion; receives reimbursement for travel expenses and honoraria.

Service on a research-related expert panel or advisory board for the following companies, with compensation as listed:

  • Boehringer Ingelheim, Chair, Global Advisory Committee on dabigatran; receives reimbursement for travel expenses and consulting fees.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with compensation as listed:

  • Bayer, Member of the Executive Steering Committee of the MARINER trial of rivaroxaban for prevention of venous thromboembolism in medically ill patients, receiving consulting fees.
  • Janssen Pharmaceutica, Member of the Executive Steering Committee of the PIONEER AF/PCI trial investigating the use of the oral factor Xa inhibitor, rivaroxaban, in patients with atrial fibrillation undergoing percutaneous coronary intervention, receiving consulting fees.
  • Medtronic Inc., Member of the Executive Steering Committee for the REVEAL-AF study of an implanted cardiac rhythm monitor in patients at risk of developing atrial fibrillation, receiving consulting fees.
  • Pfizer, Member of the Executive Steering Committee of the EMANATE trial investigating the use of the oral factor Xa inhibitor, apixaban, in patients with recently diagnosed atrial fibrillation undergoing cardioversion, receiving consulting fees.

Post-marketing clinical research, from the following company:

  • Boehringer Ingelheim, Member of the Executive Steering Committee of the GLORIA-AF Registry, which is evaluating the selection and initiation of anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation; receiving consulting fees.

Work as an author or editor for the following companies, with compensation as listed:

  • American College of Cardiology Foundation, Deputy Editor of the Journal of American College of Cardiology, receiving reimbursement for travel.

Dr. Halperin serves in significant roles with the following organization(s), with compensation as listed:

  • HWL, LLC, a software company enabling physicians to access clinical data presented through a highly usable design interface, receiving compensation.

Dr. Halperin serves in significant roles with the following organization(s), receiving reimbursement or compensation as listed:

  • American College of Cardiology, co-Chair, Competency Management Committee, receiving reimbursement for travel expenses.
  • American College of Cardiology and American Heart Association, Chair, ACC/AHA Task Force on Practice Guidelines, receiving reimbursement for travel expenses.

Dr. Halperin also serves on the Antithrombotic Trials Leadership and Steering (ATLAS) Group, an academic research organization developing cardiovascular clinical trials in the field of antithrombotic therapy, receiving consulting fees.

Barbara Hutchinson, MD, PhD

Dr. Hutchinson is the Managing Partner of Chesapeake Cardiac Care, P.A., a cardiology practice located in Annapolis, Maryland. She is board certified in Internal Medicine, Cardiovascular Disease and Sleep Medicine. Dr. Hutchinson is also an instructor in the Department of Internal Medicine at University of Maryland Medical Center in Baltimore, Maryland.

Previously, Dr. Hutchinson was Medical Director of the Heart and Vascular Unit at Anne Arundel Medical Center and Intensivist at Mercy Medical Center. She was the first African American to hold the title of Chief Resident in Internal Medicine at University of Maryland Hospital. She was also a lecturer in Pharmacology at University of District of Columbia, DC, in the Department of Respiratory Therapy.

Dr. Hutchinson is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. She is President of the Association of Black Cardiologists, and a Fellow of the American College of Cardiology (FACC). Patients from all over the world seek her out. She is a noted speaker on heart disease in women and how sleep affects heart health. Additionally, Dr. Hutchinson is the recipient of numerous awards for her work.

Dr. Hutchinson was born in Trinidad and Tobago and she earned her bachelor of science degree in chemistry at the University of the West Indies. She earned her doctoral degree in cardiovascular pharmacology from Howard University in Washington, District of Columbia, and her medical degree and subsequent fellowship in cardiology from the University of Maryland in Baltimore, Maryland.

As of January 2017, Dr. Hutchinson reported the following external relationships:

Dr. Hutchinson serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Association of Black Cardiologists, serving as President, without compensation.

Thomas J. Ryan, MD

Dr. Ryan is board certified in Internal Medicine and Cardiovascular Disease and is the Director of The Ohio State University Heart and Vascular Center. He holds the John G. and Jeanne Bonnet McCoy Chair in Cardiovascular Medicine and leads the Medical Center's Heart Program. Dr. Ryan also serves as a Professor of Cardiovascular Medicine at The Ohio State's Medical Center.

Previously, Dr. Ryan served as the Vice Chief for Clinical Services at Duke University Medical Center. He was also the Director of the Duke Heart Center and Duke University Medical Center's Echocardiography Laboratory. Prior to joining the Duke University Medical Center, Dr. Ryan served as the Staff Physician of the Veterans Administration Hospital in Durham, North Carolina. Previous to his tenure at Duke, he served in a number of roles at the Indiana University School of Medicine, including Chief of Cardiology of the Wishard Memorial Hospital; co-Director, Medicine-Pediatrics and Transitional Residency Training Programs; Director of Ultrasound Animal Laboratory; Research Associate; Director of Echocardiography Laboratory; and Staff Physician.

Dr. Ryan is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. He has authored or co-authored more than 200 published articles, book chapters and abstracts. He is a national expert on cardiac ultrasound technology, and co-author of “Feigenbaum's Echocardiography,” the leading textbook in the field of cardiovascular ultrasound. Dr. Ryan is a member of several professional organizations, including the American Society of Echocardiography, of which he is a former President.

Dr. Ryan earned his medical degree from Indiana University School of Medicine and holds a master's degree in business administration from Duke University Fuqua School of Business in Durham, North Carolina. He completed an internship and residency in internal medicine and a fellowship in cardiology at Indiana University.

As of January 2017, Dr. Ryan reported the following external relationships:

Funding for clinical trial expenses and staff, paid to The Ohio State University, from the following companies:

  • BioVentrix, to provide echocardiography core lab work for a clinical trial.
  • Medtronic Inc., to provide echocardiography core lab work for a clinical trial.

Work as an author or editor for the following company, with compensation as listed:

  • Wolters Kluwer Health, receiving royalties for an echocardiography textbook.

Dr. Ryan serves in significant roles with the following organization(s), receiving reimbursement or compensation as listed:

  • American Society of Echocardiography, Committee Member, receiving honoraria and reimbursement for travel expenses.

Chittur A. Sivaram, MD

Bio coming soon.

As of January 2017, Dr. Sivaram reported the following external relationships:

Service on data and safety monitoring boards for the following companies, with compensation for travel expenses and/or honoraria, paid to the University of Oklahoma:

  • Medtronic Inc., for a trial of a bioprosthetic valve in aortic position, receiving honoraria.
  • NaviGate Cardiac Structures, Inc., for a trial of newer valve devices, receiving honoraria and reimbursement for travel expenses.

Dr. Sivaram serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American College of Cardiology, Member of the Competency Management Committee, Member of the Life Long Learning Oversight Committee, without compensation.